A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B.
about
Emerging antivirals for the treatment of hepatitis B.Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients.Long-term treatment efficacy and safety of clevudine therapy in naïve patients with chronic hepatitis B.Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B.Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failuresVirological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients.Therapeutic advances in the management of chronic hepatitis B infection.Adverse effects of oral antiviral therapy in chronic hepatitis B.Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.Adefovir dipivoxil in chronic hepatitis B: history and current uses.Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.A comparison of clevudine and entecavir for treatment-naïve patients with chronic hepatitis B: results after 2 years of treatment.Molecular and clinical aspects of hepatitis D virus infections.Concomitant food intake does not affect the efficacy of entecavir in chronic hepatitis B patients with virological response: a randomized, multicenter, noninferiority trial
P2860
Q33801328-69AC0FE6-FF08-4E81-AEAB-94A1A87410F0Q34948124-487331BE-C049-4F1E-95E9-2C94000F5A86Q36385195-B4144578-1150-4F93-A8E8-D4E0BA37DBAAQ36492609-45DC9CFA-BD24-4528-AFDB-6A89DCDD023FQ36492640-8EFB9296-0D2F-447C-B473-57B51006209AQ36957080-25A3D1E3-CD8E-4C93-808C-B19FC8DDC2BFQ36971785-D8637D06-EE91-43E0-B774-363D47E00C10Q37651892-FC03DF2D-D6F1-43C4-A002-C86E1AAB5691Q37964712-F4A975FC-B0D8-418D-BBBB-6AE2C432795AQ37975548-A9A07965-31F0-4700-8A57-A68B6F39178DQ39754936-54ABE2E4-E222-46E8-A5E5-78C378951323Q40707675-206655DC-21A7-414F-B26A-66823F3491D8Q42969554-C061F347-401F-4F0F-8235-B6DB2A516D82Q59135102-3BAE0F55-7EDB-4C3B-B030-23BD249C4518
P2860
A comparison of 48-week treatment efficacy between clevudine and entecavir in treatment-naïve patients with chronic hepatitis B.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@ast
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@en
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@nl
type
label
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@ast
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@en
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@nl
prefLabel
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@ast
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@en
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@nl
P2093
P2860
P1476
A comparison of 48-week treatm ...... ents with chronic hepatitis B.
@en
P2093
Byung Chul Yoo
Dong Ho Lee
Joon Hyoek Lee
Kwang Cheol Koh
Moon Seok Choi
Seung Woon Paik
Soon Mi Song
Su Rin Shin
P2860
P2888
P304
P356
10.1007/S12072-010-9238-7
P577
2011-01-01T00:00:00Z
P5875
P6179
1011616825